OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

OrganiGram Holdings Inc.TSX: OGI.TO

Gross Profit · Q2 FY2026 · quarter ended Mar 2026

Gross profit turns negative

Q2 FY2026 gross profit was -CA$9.01M, compared with CA$18.42M a year earlier. Trailing-twelve-month gross profit was -CA$8.41M.

Context

  • Gross profit amounted to 3.7% of revenue in FY2025, down 26.1 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -CA$9.01M or moves back toward the trailing-twelve-month quarterly average of -CA$2.1M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$9.01M-138.6% QoQ
Last fiscal yearSep 2025
CA$9.51M-80.0% YoY
LTMMar 2026
-CA$8.41M-113.3% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-148.9%——
1 year-80.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
9.51M CAD
Year-over-year change
-80.0%

Gross Profit vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -113.3% is the lowest of 10, against a peer median of -10.0%.
  • Gross profit amounts to 3.1% of revenue for OGI.TO, versus a peer median of 49.2%.
OGI.TO Competitors
Gross Profit for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$136.02M USD-32.2%-29.5%44.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$133.27M USD-10.0%+3.6%50.9%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$100.28M CAD-46.5%—31.5%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$75.4M CAD+9.0%+73.8%47.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$47.19M USD+69.1%+204.4%92.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$37.95M USD+33.5%+26.5%74.5%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$34.41M USD-27.0%-24.8%61.7%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$281.1K USD-30.3%——
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$8.41M CAD-113.3%—3.1%
Peer median (excluding OGI.TO) —-10.0%+15.1%49.2%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.